<DOC>
	<DOCNO>NCT00946543</DOCNO>
	<brief_summary>RATIONALE : Specialized radiation therapy delivers high dose radiation directly tumor may kill tumor cell cause less damage normal tissue . PURPOSE : This phase I trial study best dose intensity-modulated radiation therapy treat patient prostate cancer .</brief_summary>
	<brief_title>Intensity-Modulated Radiation Therapy Treating Patients With Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To test feasibility deliver hypofractionated intensity-modulated radiotherapy prostate pelvic node patient prostate cancer . - To determine optimal dose level treatment regimen use future study . OUTLINE : Patients stratify accord small bowel total volume ( low small bowel volume &lt; 450 cc v high small bowel volume ≥ 450 cc ) . Patients undergo hypofractionated intensity-modulated radiotherapy prostate pelvis 4 week absence disease progression unacceptable toxicity . After completion study treatment , patient follow every 6 month 5 year annually thereafter .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis prostate cancer meet 1 follow criterion : Stage T3b/T4 disease radiological pathological pelvic nodal metastases Localized disease ( stage pT2T4 ) &gt; 30 % estimate risk pelvic nodal metastasis Highrisk ( Gleason score ≥ 8 ≥ 2 risk factor ) highrisk disease accord National Collaborative Cancer Network ( NCCN ) Has undergone prostatectomy AND stage T2T3a , N0 disease extensive highrisk disease ( Gleason score ≥ 8 ) seminal vesicle lymph node involvement Candidate radical radiotherapy PATIENT CHARACTERISTICS : No inflammatory bowel disease small bowel disease PRIOR CONCURRENT THERAPY : No prior pelvic radiotherapy surgery ( exclude prostatectomy )</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
</DOC>